These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10353313)

  • 1. Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential.
    Perkins MA; Osborne R; Rana FR; Ghassemi A; Robinson MK
    Toxicol Sci; 1999 Apr; 48(2):218-29. PubMed ID: 10353313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics.
    Faller C; Bracher M; Dami N; Roguet R
    Toxicol In Vitro; 2002 Oct; 16(5):557-72. PubMed ID: 12206823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach for development of alternative test methods based on mechanisms of skin irritation.
    Osborne R; Perkins MA
    Food Chem Toxicol; 1994 Feb; 32(2):133-42. PubMed ID: 8132172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test.
    Spielmann H; Hoffmann S; Liebsch M; Botham P; Fentem JH; Eskes C; Roguet R; Cotovio J; Cole T; Worth A; Heylings J; Jones P; Robles C; Kandárová H; Gamer A; Remmele M; Curren R; Raabe H; Cockshott A; Gerner I; Zuang V
    Altern Lab Anim; 2007 Dec; 35(6):559-601. PubMed ID: 18186667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat epidermal keratinocyte organotypic culture (ROC) as a model for chemically induced skin irritation testing.
    Pappinen S; Pasonen-Seppänen S; Suhonen M; Tammi R; Urtti A
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):233-41. PubMed ID: 16239167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and human testing strategies for skin irritation.
    Robinson MK; Osborne R; Perkins MA
    Ann N Y Acad Sci; 2000; 919():192-204. PubMed ID: 11083109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of eye and skin irritation of arginine-derivative surfactants using different in vitro endpoints as alternatives to the in vivo assays.
    Martinez V; Corsini E; Mitjans M; Pinazo A; Vinardell MP
    Toxicol Lett; 2006 Jul; 164(3):259-67. PubMed ID: 16472949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Blend of Taurine and Aloe Vera Extract Boosts Action Against Skin Irritation:
    Seo JM; Cheng S; Soliman N; Nabi Z; Pan L
    J Cosmet Sci; 2018; 69(3):213-228. PubMed ID: 30052195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an in vitro corrosion/irritation prediction assay using the EpiDerm skin model.
    Kidd DA; Johnson M; Clements J
    Toxicol In Vitro; 2007 Oct; 21(7):1292-7. PubMed ID: 17936572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants.
    Korting HC; Schindler S; Hartinger A; Kerscher M; Angerpointner T; Maibach HI
    Life Sci; 1994; 55(7):533-40. PubMed ID: 8041231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro skin irritation testing with human skin cell cultures.
    Osborne R; Perkins MA
    Toxicol In Vitro; 1991; 5(5-6):563-7. PubMed ID: 20732078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro testing of tensides employing monolayer cultures: a comparison with results of patch tests on human volunteers.
    Benassi L; Bertazzoni G; Seidenari S
    Contact Dermatitis; 1999 Jan; 40(1):38-44. PubMed ID: 9928803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo comparison of dermal irritancy of jet fuel exposure using EpiDerm (EPI-200) cultured human skin and hairless rats.
    Chatterjee A; Babu RJ; Klausner M; Singh M
    Toxicol Lett; 2006 Dec; 167(2):85-94. PubMed ID: 17049765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro skin irritation: facts and future. State of the art review of mechanisms and models.
    Welss T; Basketter DA; Schröder KR
    Toxicol In Vitro; 2004 Jun; 18(3):231-43. PubMed ID: 15046769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process.
    Cotovio J; Grandidier MH; Portes P; Roguet R; Rubinstenn G
    Altern Lab Anim; 2005 Aug; 33(4):329-49. PubMed ID: 16185103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data.
    Jírová D; Basketter D; Liebsch M; Bendová H; Kejlová K; Marriott M; Kandárová H
    Contact Dermatitis; 2010 Feb; 62(2):109-16. PubMed ID: 20136894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants.
    Ponec M; Kempenaar J
    Skin Pharmacol; 1995; 8(1-2):49-59. PubMed ID: 7786525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and intralaboratory evaluation of an in vitro human cell-based test to aid ocular irritancy assessments.
    Osborne R; Perkins MA; Roberts DA
    Fundam Appl Toxicol; 1995 Nov; 28(1):139-53. PubMed ID: 8566478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro skin irritancy: application of keratinocytes cell culture and its correlation with human patch test responses.
    Eun HC
    Curr Probl Dermatol; 1995; 22():231-6. PubMed ID: 7587328
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of interleukin-1alpha in human NCTC 2544 keratinocyte cells as a predictor of skin irritation from lysine-based surfactants.
    Sanchez L; Mitjans M; Infante MR; Vinardell MP
    Toxicol Lett; 2006 Nov; 167(1):40-6. PubMed ID: 16996234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.